WEITERE NEUE FORMEN VON INTERFERIERENDE RNS MOLEKÜLE

European patent · EP2258847 · Deleted

Register entry

Publication number
EP2258847
Application number
EP10012263
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Maintained in amended form
Filed
Aug 5, 2003
Published
Dec 8, 2010
Granted
Mar 15, 2017
Deleted
Aug 5, 2023
Reason
Maximum term reached
IPC classes
C12N 15/113 (2010.01)
A61K 31/713 (2006.01)
//C07H 21/00 (2006.01)
//C12Q 1/68 (2006.01)
//A01K 67/027 (2006.01)
//C12N 5/10 (2006.01)
Priority
EP 02017601 05.08.2002
US 402541 P 12.08.2002
EP 03008383 10.04.2003
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 5, 2023

    Maximum term reached

    Published in Swissreg on 05.08.2023

  2. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  3. Sep 23, 2021

    Change

    Published in Swissreg on 23.09.2021

  4. Sep 23, 2021

    Change

    Published in Swissreg on 23.09.2021

  5. Sep 23, 2021

    Change

    Published in Swissreg on 23.09.2021

  6. Sep 23, 2021

    Change

    Published in Swissreg on 23.09.2021

  7. Jun 3, 2020

    Change

    Published in Swissreg on 03.06.2020

  8. Mar 15, 2017

    Granted

    Published in Swissreg on 15.03.2017

Parties

Holder

Silence Therapeutics GmbH

Robert-Rössle-Strasse 10, 13125 Berlin, DE

Inventor

Giese, Klaus

Robert-Rössle-Str. 10, 13125 Berlin, DE

Kaufmann, Jörg

13465 Berlin, DE

Klippel-Giese, Anke

13125 Berlin, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.